FindTrial
Sign In

Therapeutic effect of autologous adipose tissue derived stromal vascular fraction to neuropathic pain syndrome; Preliminary report

A preliminary study on the therapeutic effect of autologous adipose stem cell transplantation for patients with intractable neuropathic pain

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006517
Enrollment
10
Registered
2021-08-31
Start date
2020-05-07
Completion date
Unknown
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who Chronic neuropathic pain persists for more than 6 months during the treatment period after diagnosis, Dispite the current analgesic drug treatment and surgical treatment, the pain relief is insignificant, and presistnat severe pain Complex regional pain syndrome, failed Back Surgery Syndrome, postherpetic neuralgia, and posttraumatic neuralgia

Exclusion criteria

Exclusion criteria: Cancer pain patients, intervertebral disc-caused pain patients, joint pain patients, hepatitis B, hepatitis C, HIV-positive patients

Design outcomes

Primary

MeasureTime frame
Evaluation of the Neuropathy Pain Scale (NPS) follow-up—

Secondary

MeasureTime frame
Evaluation of the Visual analog scale (VAS) follow-up—

Countries

Korea, Republic of

Contacts

Public ContactSoo Young Kim

Hanyang University Seoul Hospital

a01055398745@gmail.com+82-2-2290-8491

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026